Adolescent lumbar disc herniation: etiology, diagnosis, and treatment options.
Adolescent lumbar disc herniation: rising incidence, unique diagnosis, and evolving treatment options. 📈🩺
AI Agents Enhancing Clinical Decision-Making in Oncology
AI agents are improving clinical decision-making in oncology, achieving 91% accuracy in simulated patient cases. 🤖💉
Artificial intelligence-based tumor size measurement on mammography: agreement with pathology and comparison with human readers’ assessments across multiple imaging modalities.
AI tumor size measurement shows 52% discordance with pathology in breast cancer. 📊🤖 Further refinement needed.
AI Tool Enhances Skin Cancer Detection for Physicians
AI tool PanDerm improves skin cancer detection accuracy by 11% for doctors, aiding early diagnosis and treatment. 🩺🌍
Recent advances and challenges in colorectal cancer: From molecular research to treatment.
Colorectal cancer's global impact: 1.9 million cases in 2020. AI and organoids offer hope amid treatment challenges. 🧬💊
Call for Enhanced FDA Regulation of AI in Healthcare
Title: FDA Regulation of AI in Healthcare Needs Improvement 🏥🤖 Experts urge the FDA to enhance oversight of AI tools to ensure patient safety and address biases.
The Next Frontiers in Preventive and Personalized Healthcare: Artificial Intelligent-Powered Solutions.
AI in healthcare: Enhancing diagnostics, treatment, and patient outcomes through data-driven insights and real-time monitoring. 📊🤖
Data extraction from free-text stroke CT reports using GPT-4o and Llama-3.3-70B: the impact of annotation guidelines.
GPT-4o outperforms Llama-3.3-70B in stroke CT report data extraction, precision improved with annotation guidelines. 📊🧠
North Bristol NHS Trust Achieves Milestone with Over 9,000 Robotic Surgeries
North Bristol NHS Trust has completed over 9,000 robotic surgeries, enhancing patient care and reducing waiting times. 🤖🏥
Personalized translational medicine: Investigating YKL-40 as early biomarker for clinical risk stratification in hepatocellular carcinoma recurrence post-liver transplantation.
YKL-40 shows promise as a biomarker for HCC recurrence post-liver transplantation, enhancing risk stratification. 📊🔍